pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
201 |
4. Check minimum number of eventsNone |
201 |
5. Include endpointsNone |
201 |
6. Filter based on genotype QC (FinnGen only) |
201 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum partis endocrinae pancreatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Endocrine pancreas
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Endocrine pancreas
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 826 | 449 | 372 |
| Only index persons | 764 | 421 | 343 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 64.35 | 64.03 | 64.77 |
| Only index persons | 63.60 | 62.65 | 64.76 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 201 | 88 | 113 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 63.92 | 60.64 | 66.46 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 178
- Matched controls
- 1780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
+∞
240.9
172
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
85.0
69.2
75
15
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
36.1
33.0
42
15
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
22.6
24.2
35
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.3
21.5
57
108
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
87.2
21.2
23
*
JLC10
NOMESCO Finland
Distal pancreatectomy
118.3
20.0
21
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
10.4
16.6
33
38
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
15.9
15
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
18.3
15.8
24
15
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
15.5
36
54
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
14.8
14
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
58.2
14.1
16
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
81.2
13.8
15
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
37.3
13.8
17
5
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
13.7
13
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.6
13.5
36
66
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.0
13.1
33
56
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
12.6
12
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
19.8
12.3
18
10
K86.2
ICD-10 Finland
Cyst of pancreas
29.1
12.3
16
6
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
11.6
11
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
37.7
11.4
14
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
37.7
11.4
14
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.1
11.1
88
430
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
46.5
11.1
13
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.6
11.0
33
70
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
19.4
10.9
16
9
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
9.7
71
323
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
+∞
9.5
9
*
JN4CD
NOMESCO Finland
Very extensive body CT
6.6
9.1
23
39
JN4AD
NOMESCO Finland
Body CT examination
4.6
8.6
30
75
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
8.6
8.6
18
23
JLC30
NOMESCO Finland
Pancreatoduodenectomy
29.1
8.6
11
*
JN4BD
NOMESCO Finland
Extensive body CT
3.7
8.2
37
118
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
8.1
85
466
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
83.4
7.5
8
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
83.4
7.5
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
7.2
41
156
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
41.7
6.8
8
*
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
41.7
6.8
8
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
12.9
6.7
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.7
98
623
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.6
67
352
E34.0
ICD-10 Finland
Carcinoid syndrome
72.3
6.5
7
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
6.4
28
87
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.6
6.4
11
10
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
18.8
6.3
9
5
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
27.8
6.3
8
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
27.8
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
80
199
6.02
32.77
3.1
4.8
ug/l
2.9
27.2
0.63
59
170
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
48
9.22
27.76
1.8
1.5
ug/g
229.1
296.6
0.89
28
29
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
46
80
7.16
26.77
2.3
3.2
u/ml
34.5
526.2
0.69
40
66
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
573
4.04
20.99
3.7
2.6
u/l
60.5
55.0
0.48
118
528
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
151
806
4.51
20.60
8.0
5.9
mmol/l
1.2
1.2
0.29
143
739
(3024561) Albumin [Mass/volume] in Serum or Plasma
144
770
4.07
18.94
7.3
4.9
g/l
34.6
35.3
0.73
139
733
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
155
882
4.31
18.36
11.0
6.9
mmol/l
1.2
1.2
0.21
121
743
(3032080) INR in Blood by Coagulation assay
139
740
3.85
18.08
15.3
10.0
inr
1.3
1.3
0.06
53
233
(3018418) pH of Serum or Plasma
113
546
3.44
16.74
4.8
4.0
ph
7.4
7.4
0.34
31
122
(3016244) Insulin [Units/volume] in Serum or Plasma
20
5
44.06
16.67
4.5
1.0
mu/l
12.2
8.4
—
20
5
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
54
164
4.13
16.20
2.7
2.5
u/l
304.7
33.5
0.55
46
136
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
48
134
4.39
16.10
4.6
3.9
ng/l
89.0
81.2
0.28
41
119
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
25
8.29
13.80
1.6
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
25
8.29
13.80
1.4
1.2
nmol/l
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
158
1040
3.43
12.27
8.0
4.9
mmol/l
7.0
6.9
0.29
152
968
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
105
559
2.84
11.98
2.9
3.3
u/l
31.7
32.1
0.04
99
538
(4035726)
48
170
3.40
11.19
1.6
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
87
441
2.72
10.62
4.0
3.9
%
91.9
88.2
0.59
87
435
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
117
701
2.60
9.97
3.1
2.2
nmol/l
82.1
76.2
1.10
110
613
(3035637) Corticotropin [Mass/volume] in Plasma
12
14
9.05
9.44
2.2
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
43
161
3.13
9.04
4.4
4.2
mmol/l
1.2
1.2
0.09
36
149
(3012095) Magnesium [Moles/volume] in Serum or Plasma
64
306
2.60
8.49
3.1
3.3
mmol/l
0.8
0.8
0.54
64
287
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
109
669
2.37
8.31
3.2
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
92
526
2.38
8.24
3.2
3.1
e6/l
1.5
0.5
0.32
71
395
(36304419) Bacteria [Presence] in Urine
89
504
2.37
8.12
3.3
3.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
49
210
2.76
8.02
8.2
7.4
kpa
5.1
5.1
0.22
49
203
(3014576) Chloride [Moles/volume] in Serum or Plasma
54
244
2.66
7.98
6.9
7.0
mmol/l
106.4
103.8
4.74
54
237
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
123
811
2.33
7.74
5.6
4.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
48
210
2.69
7.52
8.3
7.4
kpa
14.0
12.1
1.32
48
204
(3016502) Oxygen saturation in Arterial blood
45
191
2.75
7.47
8.5
7.9
%
96.2
96.0
0.06
45
186
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
214
2.63
7.23
2.5
3.4
umol/l
9.6
9.2
0.04
41
188
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
208
2.64
7.18
5.2
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
94
572
2.21
6.97
3.4
3.3
e6/l
215.0
60.0
0.46
72
441
(3020891) Body temperature
24
75
3.50
6.67
4.5
4.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
157
2.75
6.60
4.8
4.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
151
1128
2.36
6.53
4.9
4.5
—
379.9
—
0
23
(3020682) Albumin/Creatinine [Ratio] in Urine
92
567
2.15
6.49
4.2
4.2
mg/mmol
8.6
8.1
0.03
54
370
(3009508) Creatinine [Moles/volume] in Urine
90
559
2.10
6.14
3.2
3.2
mmol/l
7.0
7.7
0.96
77
455
(3012501) Base excess in Blood by calculation
17
44
4.13
6.12
4.9
2.5
mmol/l
2.8
2.3
0.34
11
26
(3012516) Albumin [Mass/volume] in Urine
87
538
2.09
5.97
3.1
3.4
mg/l
59.6
167.0
0.44
51
356
(40768804) Tissue Pathology biopsy report
102
680
2.02
5.60
2.4
2.2
—
—
—
0
0
(3010421) pH of Blood
17
48
3.78
5.45
5.3
2.6
ph
7.4
7.4
0.16
17
43
(40768797) Stomach Pathology biopsy report
48
242
2.29
5.44
1.6
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
90
579
2.00
5.41
4.7
3.3
mmol/l
2.4
2.3
1.24
84
507
(3018095) Leukocytes [#/volume] in Urine
98
650
1.99
5.40
4.0
3.8
e6/l
59.9
76.8
0.17
74
472
(3044640) Blood type and Crossmatch panel - Blood
86
549
1.99
5.25
2.9
2.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
119
851
1.98
5.21
4.4
3.8
estimate
0.0
0.0
0.00
38
184
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
144
1114
2.03
4.87
5.3
3.2
u/l
68.3
50.7
0.69
137
1033
(3009261) Glucose [Presence] in Urine by Test strip
119
864
1.92
4.84
4.4
3.9
estimate
0.0
0.0
0.00
36
177
(3025159) Blasts/100 leukocytes in Blood
31
136
2.51
4.74
4.5
5.1
%
0.0
0.0
—
8
40
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
75
471
1.94
4.70
1.7
1.7
mmol/l
1.5
1.3
0.57
62
382
(3007853) Bacteria identified in Skin by Aerobe culture
42
214
2.22
4.60
1.4
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
117
854
1.89
4.59
5.9
5.2
estimate
0.0
0.0
0.00
36
185
(3044889) 12 lead EKG panel
154
1232
2.07
4.59
5.4
4.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
8
10.35
4.56
3.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
155
1246
2.07
4.51
4.4
3.7
pmol/l
15.0
14.9
0.07
143
1108
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
115
2.56
4.39
1.9
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
30
136
2.42
4.28
4.6
4.9
%
0.8
0.3
—
8
34
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
1007
1.86
4.20
10.2
9.3
e9/l
4.5
4.2
0.82
118
881
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
283
2.02
4.16
2.8
3.0
e6/l
1.1
2.1
0.79
21
155
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
23
4.52
4.14
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
42
3.51
4.12
4.8
3.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
14
6.67
4.03
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
108
790
1.79
4.01
16.2
10.5
e9/l
0.0
0.0
0.50
93
646
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
47
265
2.01
3.93
3.0
2.5
%
21.8
22.7
0.13
40
232
(40758558) Short blood count panel - Blood
67
426
1.86
3.93
8.3
7.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
142
2.31
3.89
4.8
5.0
%
0.1
0.2
—
9
47
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
56
338
1.91
3.85
4.1
2.9
mmol/l
2.5
2.5
1.67
50
292
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
188
1669
2.95
3.78
6.5
4.8
mmol/l
6.5
6.1
2.14
181
1522
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
50
3.16
3.77
1.2
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
726
1.75
3.72
4.4
4.0
ng/l
39.7
47.4
0.24
76
539
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
433
1.82
3.70
2.4
2.0
mg/l
3.4
3.2
0.26
62
374
(42870588) Differential panel, method unspecified - Blood
84
581
1.77
3.70
5.6
5.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
46
263
1.97
3.69
2.3
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
76
512
1.78
3.65
5.5
4.4
—
—
—
0
0
(3002256) Pathology report gross observation
40
222
2.00
3.48
1.6
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
78
537
1.74
3.44
2.0
2.1
u/l
177.6
216.0
0.25
72
504
(3003694) ABO and Rh group [Type] in Blood
66
433
1.78
3.44
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
27
3.85
3.40
3.1
4.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
158
2.14
3.37
4.7
4.8
%
0.8
0.9
—
8
53
(3000991) Gas panel - Venous blood
30
151
2.16
3.37
6.5
8.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
182
1610
2.38
3.35
8.9
6.2
mmol/mol
41.8
40.6
0.86
176
1498
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
7
8.79
3.28
2.7
1.4
umol/l
26.7
30.1
—
6
7
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
307
1.84
3.21
2.7
2.7
e6/l
1.1
1.2
0.08
22
177
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
176
1545
2.12
3.16
5.2
4.6
mu/l
1.9
1.9
0.09
162
1379
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
39
3.21
3.14
4.6
3.2
%
52.5
60.5
0.98
12
39
(3008152) Bicarbonate [Moles/volume] in Arterial blood
25
120
2.24
3.14
11.8
6.6
mmol/l
25.0
24.6
0.23
25
114
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
188
1696
2.68
3.14
25.0
15.6
mg/l
33.1
23.5
2.22
175
1356
(40760892) CBC W Ordered Manual Differential panel - Blood
61
403
1.74
3.06
5.0
5.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
143
1185
1.72
3.00
4.8
4.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
66
448
1.70
3.00
1.5
1.5
nmol/l
21.1
21.3
0.04
59
377
(3029937) Albumin [Presence] in Urine by Test strip
70
484
1.68
2.96
4.9
4.1
estimate
0.0
0.0
0.00
32
179
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
96
2.33
2.95
12.7
9.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
58
2.71
2.95
2.2
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
197
1.94
2.92
1.5
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
676
1.63
2.91
4.9
4.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
97
2.30
2.89
7.8
10.2
mmol/l
23.2
24.5
0.98
21
91
(3026493) Urate [Moles/volume] in Serum or Plasma
69
479
1.67
2.86
2.3
3.0
umol/l
390.5
9106.6
2.59
54
406
(3001604) Monocytes [#/volume] in Blood
112
878
1.62
2.86
5.7
5.7
e9/l
0.7
0.6
1.25
101
761
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
42
2.98
2.80
1.2
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
112
881
1.61
2.80
5.7
5.7
e9/l
0.0
0.0
0.55
101
766
(3019309) Folate [Moles/volume] in Red Blood Cells
52
338
1.73
2.73
2.5
1.7
nmol/l
1315.2
1240.1
0.22
43
262
(3026008) Bacteria identified in Urine by Culture
72
514
1.62
2.65
3.6
3.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
25
129
2.07
2.64
8.9
4.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
18
81
2.34
2.63
2.4
2.0
ug/l
8.8
5.7
0.20
18
75
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
401
1.67
2.63
2.1
1.7
pmol/l
454.8
442.3
0.15
46
324
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
38
3.00
2.62
3.6
2.7
e9/l
3.5
4.9
1.46
11
38
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
20
4.12
2.59
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
75
2.38
2.59
2.8
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
490
1.62
2.58
4.1
3.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
112
893
1.57
2.56
5.7
5.8
e9/l
1.9
1.9
0.09
102
795
(3013115) Eosinophils [#/volume] in Blood
113
903
1.57
2.55
5.7
5.9
e9/l
0.2
0.2
0.19
102
802
(3023103) Potassium [Moles/volume] in Serum or Plasma
191
1763
2.68
2.52
32.3
18.2
mmol/l
4.0
4.0
0.62
191
1719
(3019550) Sodium [Moles/volume] in Serum or Plasma
191
1764
2.66
2.50
32.4
18.0
mmol/l
139.6
139.7
0.10
191
1720
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
203
1.81
2.37
1.9
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
203
1.81
2.37
1.9
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
91
701
1.54
2.37
3.3
2.6
ug/l
164.4
145.3
0.23
85
644
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
23
3.58
2.29
1.0
1.2
—
21.0
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
167
1.86
2.26
1.6
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
192
1803
2.45
2.23
31.7
18.5
umol/l
86.4
81.1
0.78
192
1803
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
9
5.66
2.22
4.2
8.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
169
1.84
2.19
2.9
2.9
e9/l
60.6
72.1
1.15
24
131
(3013707) Erythrocyte sedimentation rate by Westergren method
148
1283
1.58
2.15
4.6
4.2
mm/h
13.0
12.4
0.18
135
1170
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
387
1.58
2.09
4.2
3.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
141
1.88
2.08
2.6
3.0
ml/min/173m2
60.3
60.5
0.01
13
63
(40761511) CBC panel - Blood by Automated count
190
1773
2.31
2.02
25.9
14.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
64
2.28
1.99
5.2
3.5
mmol/l
3.8
3.9
0.24
14
56
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
53
374
1.57
1.99
1.6
1.8
mg/l
2.4
1.5
0.52
41
292
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
21
3.41
1.98
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
349
1.58
1.96
1.3
1.2
u/ml
0.9
0.9
0.03
12
91
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
27
3.04
1.96
4.0
1.6
ug/l
15.2
15.6
—
8
27
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
11
4.63
1.95
2.6
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
39
2.65
1.95
4.4
2.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
286
1.59
1.82
2.0
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
417
1.51
1.81
3.1
2.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
74
2.11
1.80
1.8
1.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
7
24
2.98
1.74
2.3
4.4
%
2.6
1.0
—
7
19
(3004451) EKG impression Narrative
5
13
3.91
1.72
1.6
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
13
3.91
1.72
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
90
1.97
1.71
1.3
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
577
1.45
1.70
3.0
3.3
ng/l
1601.1
1347.7
0.22
63
484
(3023419) Bacteria identified in Sputum by Culture
8
31
2.64
1.68
2.0
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
49
2.32
1.67
1.3
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
14
3.63
1.62
1.0
1.1
u/l
49.2
48.6
—
5
9
(3013512) EKG study
71
555
1.43
1.59
4.7
4.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
22
132
1.75
1.53
1.5
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
15
3.39
1.53
1.8
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
738
1.40
1.53
2.3
1.9
pmol/l
91.1
95.8
0.48
53
391
(3026389) Candida sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
21
2.91
1.51
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
102
1.84
1.50
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
176
1632
1.63
1.48
23.5
14.7
ml/min/173m2
76.8
78.6
0.48
165
1345
(40768800) Prostate Pathology biopsy report
12
59
2.10
1.47
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
39
2.37
1.45
1.3
2.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
16
3.18
1.44
2.2
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
164
1501
1.50
1.43
22.9
16.0
%
39.2
40.0
0.40
96
1045
(3007164) IgA [Mass/volume] in Serum or Plasma
44
320
1.48
1.42
1.4
1.5
g/l
2.4
2.7
0.64
27
195
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
60
2.06
1.41
1.9
4.1
—
3.2
—
0
8
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
331
1.46
1.37
5.3
3.9
ng/l
323.3
141.8
0.57
38
271
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
113
1.75
1.37
1.5
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
61
2.03
1.36
2.0
4.3
mg/l
32.2
29.2
—
7
48
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
61
2.03
1.36
2.0
4.3
mg/l
38.2
150.4
—
7
48
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.4
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
44
2.09
1.28
1.3
1.3
—
3.5
—
0
7
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
45
2.05
1.25
1.3
1.3
—
1.6
—
0
7
(40760888) Immunoglobulin light chains.free panel - Serum
9
45
2.05
1.25
2.1
5.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
26
2.35
1.19
1.2
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
31
2.30
1.11
1.9
2.0
pg
31.1
33.1
—
7
31
(21494434) Karyotype in Bone marrow
5
21
2.41
1.09
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
46
2.00
1.05
1.8
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
22
2.30
1.04
1.4
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
23
2.20
0.98
2.4
4.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
93
1.66
0.97
2.5
2.6
—
—
—
0
0
(3012544) pH of Venous blood
25
176
1.48
0.96
4.5
4.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
37
1.92
0.95
4.0
2.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
28
2.18
0.92
2.2
2.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
28
2.18
0.92
1.2
4.3
u/ml
—
5065.4
—
0
5
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
28
2.18
0.92
1.3
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
11
63
1.79
0.92
1.9
2.2
g/l
1.1
1.0
0.07
11
58
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
44
1.85
0.87
1.0
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
30
224
1.40
0.86
1.4
1.3
titre
506.7
470.6
—
6
47
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
45
1.81
0.85
1.8
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
65
1.73
0.84
1.9
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
89
1.62
0.83
1.1
1.2
—
—
—
0
0
(4094501)
8
47
1.73
0.81
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
123
0.55
0.81
1.9
1.8
—
—
—
0
0
(4268621)
0
24
0.00
0.79
0.0
2.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
33
1.84
0.79
2.2
8.2
—
132.8
—
0
6
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
33
1.84
0.79
1.0
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
1.1
—
0
13
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.79
0.0
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.78
0.0
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
23
168
1.42
0.75
3.8
4.1
mmol/l
2.2
2.1
0.04
18
129
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
56
1.64
0.73
2.0
3.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
26
1.95
0.71
3.0
3.4
mmol/l
4.1
4.0
—
5
26
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
26
1.95
0.71
3.0
3.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
26
1.95
0.71
3.0
3.4
mmol/l
108.0
106.2
—
5
26
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
110
1.49
0.71
7.2
4.2
mmol/l
0.8
1.8
—
9
83
(3022806) Fractional oxyhemoglobin in Capillary blood
5
27
1.87
0.69
1.8
2.3
%
93.6
89.0
—
5
27
(4010399)
18
129
1.43
0.66
1.2
1.4
—
—
—
0
0
(3000492) Spirometry study
22
165
1.37
0.64
1.5
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
192
1873
1.56
0.63
39.7
22.7
g/l
131.6
136.1
3.50
192
1845
(3026361) Erythrocytes [#/volume] in Blood
192
1873
1.56
0.63
39.4
22.5
e12/l
4.4
4.5
2.36
192
1819
(3010813) Leukocytes [#/volume] in Blood
192
1873
1.56
0.63
39.4
22.6
e9/l
6.9
6.7
0.93
192
1821
(3024731) MCV [Entitic volume]
192
1872
1.57
0.63
39.3
22.5
fl
91.4
91.3
0.07
192
1846
(3035941) MCH [Entitic mass]
192
1872
1.57
0.63
39.3
22.4
pg
30.3
30.4
0.72
192
1845
(3007461) Platelets [#/volume] in Blood
192
1871
1.58
0.63
39.4
22.6
e9/l
243.9
240.8
0.27
192
1827
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
63
1.62
0.63
1.8
2.1
u/ml
0.4
0.4
—
5
34
(40761535) Cells panel - Urine sediment
20
148
1.39
0.62
4.1
3.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
30
1.68
0.62
1.4
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.1
—
0
6
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
20
0.00
0.60
0.0
1.8
—
480.4
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.9
—
0
10
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
11.0
—
0
13
(3028026) IgM [Mass/volume] in Serum or Plasma
16
115
1.43
0.58
1.4
1.6
g/l
1.0
1.5
0.50
16
103
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
35
1.74
0.58
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
54
1.50
0.58
1.4
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
36
1.69
0.57
2.3
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
55
1.47
0.57
1.4
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
37
1.64
0.56
1.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
40
1.52
0.52
1.3
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
92
1.44
0.52
4.8
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
208
1.29
0.51
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
182
1.30
0.49
1.3
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
46
1.54
0.49
1.3
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
7
46
1.54
0.49
4.3
2.9
kpa
8.1
7.8
—
7
41
(3037756) Immunofixation for Serum or Plasma
7
47
1.51
0.48
1.1
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
84
765
1.17
0.47
6.2
5.3
ug/l
2.3
2.7
0.40
76
685
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
51
1.39
0.44
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
103
957
1.16
0.44
2.7
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
122
1.34
0.44
1.1
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
4.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.9
—
0
8
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
2.0
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.4
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
65.4
—
0
6
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
42
367
1.18
0.39
4.9
4.2
kg/l
1.0
1.0
—
9
42
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
72
1.41
0.37
4.5
2.1
ug/l
379.6
354.3
—
10
66
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
265
0.81
0.37
1.0
1.3
u/ml
1.4
9.0
1.87
12
105
(3001019) Free T4 and TSH panel - Serum or Plasma
9
71
1.28
0.36
1.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
41
1.48
0.36
1.3
1.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
73
1.39
0.35
1.8
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
172
1673
1.19
0.34
5.3
4.7
mmol/l
1.4
1.4
1.91
164
1526
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
173
1684
1.20
0.34
5.5
4.8
mmol/l
4.3
4.5
2.77
165
1544
(42529406) Shigella sp [Presence] in Stool by Culture
7
52
1.36
0.31
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
52
1.36
0.31
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
54
1.31
0.30
7.1
5.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
106
0.74
0.30
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
454
1.13
0.29
3.8
3.3
ug/l
0.9
0.8
0.27
41
309
(3019225) pH of Specimen
19
160
1.21
0.26
11.3
4.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
166
1621
1.14
0.25
4.8
4.2
mmol/l
1.4
1.3
1.32
155
1475
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
8
104
0.76
0.21
2.1
2.2
e9/l
4.4
3.8
—
8
77
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
1.8
—
0
12
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
118
1.20
0.19
2.9
2.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
53
1.14
0.19
1.8
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
53
1.14
0.19
1.8
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
235
0.88
0.17
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
69
1.17
0.16
1.3
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
119
0.83
0.16
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
78
1.16
0.15
1.6
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
117
0.85
0.13
1.1
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
612
1.07
0.13
4.4
4.7
%
19.5
20.9
0.43
41
308
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
114
1.15
0.12
1.2
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
174
1719
1.09
0.12
6.1
5.3
mmol/l
2.5
2.7
2.20
165
1573
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.2
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.3
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
62
0.80
0.08
3.0
2.3
—
—
—
0
0
(1002224) Polysomnography panel
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
214
0.93
0.07
2.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
87
1.04
0.07
10.1
3.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
220
1.05
0.03
17.1
7.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
59
600
0.98
0.02
3.5
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
126
1.03
0.00
1.3
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
134
0.97
0.00
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
187
1.02
0.00
2.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
245
1.02
0.00
2.2
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
98
1.02
0.00
1.3
1.2
u/ml
35.4
161.7
—
10
88
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
282
0.99
0.00
1.1
1.3
iu/ml
10.1
33.4
—
7
99
(44806420)
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
74.5
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
59
0.84
0.00
3.0
2.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
8
89
0.89
0.00
1.4
2.0
g/l
1.7
1.5
—
8
73
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
72
0.97
0.00
1.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ENDOCRINE_PANCREAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_PANCREAS | 2.501 [1.71, 3.67] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.048 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 343 females with CD2_BENIGN_ENDOCRINE_PANCREAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_PANCREAS | 2.53 [1.48, 4.32] | < 0.001 |
| Birth year | 0.985 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 275 males with CD2_BENIGN_ENDOCRINE_PANCREAS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ENDOCRINE_PANCREAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.26% | 0.423% |
| 5 | 1.356% | 2.896% |
| 10 | 3.129% | 6.819% |
| 15 | 6.062% | 13.219% |
| 20 | 10.476% | 20.537% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS – Benign neoplasm: Endocrine pancreas
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data